Smartphone-based platforms implementing microfluidic detection with image-based artificial intelligence

Abstract

The frequent outbreak of global infectious diseases has prompted the development of rapid and effective diagnostic tools for the early screening of potential patients in point-of-care testing scenarios. With advances in mobile computing power and microfluidic technology, the smartphone-based mobile health platform has drawn significant attention from researchers developing point-of-care testing devices that integrate microfluidic optical detection with artificial intelligence analysis. In this article, we summarize recent progress in these mobile health platforms, including the aspects of microfluidic chips, imaging modalities, supporting components, and the development of software algorithms. We document the application of mobile health platforms in terms of the detection objects, including molecules, viruses, cells, and parasites. Finally, we discuss the prospects for future development of mobile health platforms.

Microsnoop: A Generalized Tool for Unbiased Representation of Diverse Microscopy Images

“…Moreover, the current training images are still limited in size compared to natural images, and a larger training data volume combined with the Transformer architecture can be studied to improve the performance. Last but not least, deploying our model on mobile devices to aid rapid detection could be a valuable application scenario 54 .…”

Plant exosome nanovesicles (PENs): green delivery platforms

“…In terms of artificial intelligence, in the context of rapid development, artificial intelligence technology has been widely used in drug research and development. 86,[150][151][152][153] Applying artificial intelligence technology to medicine provides an unprecedented vast space, but also puts forward more challenges; artificial intelligence can be used for plant-derived exosomes, and artificial intelligence for exosome composition detection, exosome target confirmation, drug screening, safety assessment, effectiveness testing, 154 data collection, etc. is a promising technology and has prospects for development.…”

Recent advances in point-of-care testing of COVID-19

“…Fig. 4 depicts various in vitro POCT devices including LFA strip, VFA strip, microfluidic, and paper-based microfluidic devices, 18 which have been widely used for COVID-19 testing during the global pandemic. These devices offer quick and accessible screenings for SARS-CoV-2 infections.…”